Curcumin Bioavailability in Glioblastoma Patients

NCT01712542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2013-06-04

No results posted yet for this study

Summary

Measuring the bioavailability of orally administered curcumin in the tumors of glioblastoma patients.

Conditions

  • Patient Harboring Glioblastoma That Will Undergo Surgery

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Stephan Duetzmann · Goethe University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01712542 on ClinicalTrials.gov